APO RESEARCH · REPORT
Tuberculosis (TB) Detection
Tuberculosis (TB) is a chronic infection caused by the bacterium tuberculosis (TB).Tuberculous bacterium invades human body all sorts of organs possibly, but basically encroach lung, call tuberculosis disease.
Product & engineering
Understand the product.
Tuberculosis (TB) is a chronic infection caused by the bacterium tuberculosis (TB).Tuberculous bacterium invades human body all sorts of organs possibly, but basically encroach lung, call tuberculosis disease.
Tuberculosis (TB) is a chronic and slow - onset infectious disease in young people.The incubation period is 4 to 8 weeks.Of these, 80% occur in the lungs, and other areas (cervical lymph, meninges, peritoneum, intestine, skin, bone) may also be secondary to infection.Transmission of respiratory tract from person to person is the main mode of transmission.Infection source is the person that contacts the tuberculosis that discharges bacterium.With the spread of environmental pollution and AIDS, the incidence of TB is becoming more and more intense.In addition to a few cases of rapid onset, clinical more chronic process.There are often low fever, fatigue and other systemic symptoms and respiratory symptoms such as cough, hemoptysis.
Selected research
Industry Research
Tuberculosis (TB) Detection Industry Research Report 2026
Market perspective
Tuberculosis (TB) is a chronic infection caused by the bacterium tuberculosis (TB).Tuberculous bacterium invades human body all sorts of organs possibly, but basically encroach lung, call tuberculosis disease.
Tuberculosis (TB) is a chronic and slow - onset infectious disease in young people.The incubation period is 4 to 8 weeks.Of these, 80% occur in the lungs, and other areas (cervical lymph, meninges, peritoneum, intestine, skin, bone) may also be secondary to infection.Transmission of respiratory tract from person to person is the main mode of transmission.Infection source is the person that contacts the tuberculosis that discharges bacterium.With the spread of environmental pollution and AIDS, the incidence of TB is becoming more and more intense.In addition to a few cases of rapid onset, clinical more chronic process.There are often low fever, fatigue and other systemic symptoms and respiratory symptoms such as cough, hemoptysis.
In Southeast Asia, Tuberculosis (TB) Detection key players include Danaher, Roche, Thermal Fisher, Abbott, etc.
Read the full market overview
Indonesia is the largest market, with a share over 20%, followed by Philippines, and Myanmar, both have a share about 30 percent.
In terms of product, Bacterial Culture Test is the largest segment, with a share about 50%. And in terms of application, the largest application is Hospital, followed by Clinic, Research Institution, etc.
Report Scope
This report quantifies the global Tuberculosis (TB) Detection market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Tuberculosis (TB) Detection.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Tuberculosis (TB) Detection Market by Company
Danaher
Roche
Thermal Fisher
Abbott
Oxford Immunotec International
Qiagen
Hologic
Hain Lifescience
Epistem
Creative Diagnostics
Tuberculosis (TB) Detection Segment by Type
Bacterial Culture Test
Tuberculin Test
Rapid Molecular Diagnosis
Other
Tuberculosis (TB) Detection Segment by Application
Hospital
Clinic
Research Institution
Other
Tuberculosis (TB) Detection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tuberculosis (TB) Detection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Tuberculosis (TB) Detection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tuberculosis (TB) Detection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Tuberculosis (TB) Detection companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Bacterial Culture Test
- Tuberculin Test
- Rapid Molecular Diagnosis
- Other
Applications
- Hospital
- Clinic
- Research Institution
- Other
Companies covered
- Danaher
- Roche
- Thermal Fisher
- Abbott
- Oxford Immunotec International
- Qiagen
- Hologic
- Hain Lifescience
- Epistem
- Creative Diagnostics
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Tuberculosis (TB) Detection by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Bacterial Culture Test
- 2.2.3 Tuberculin Test
- 2.2.4 Rapid Molecular Diagnosis
- 2.2.5 Other
- 2.3 Tuberculosis (TB) Detection by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital
- 2.3.3 Clinic
- 2.3.4 Research Institution
- 2.3.5 Other
- 2.4 Assumptions and Limitations
3 Tuberculosis (TB) Detection Breakdown Data by Type
- 3.1 Global Tuberculosis (TB) Detection Historic Market Size by Type (2021-2026)
- 3.2 Global Tuberculosis (TB) Detection Forecasted Market Size by Type (2027-2032)
4 Tuberculosis (TB) Detection Breakdown Data by Application
- 4.1 Global Tuberculosis (TB) Detection Historic Market Size by Application (2021-2026)
- 4.2 Global Tuberculosis (TB) Detection Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Tuberculosis (TB) Detection Market Perspective (2021-2032)
- 5.2 Global Tuberculosis (TB) Detection Growth Trends by Region
- 5.2.1 Global Tuberculosis (TB) Detection Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Tuberculosis (TB) Detection Historic Market Size by Region (2021-2026)
- 5.2.3 Tuberculosis (TB) Detection Forecasted Market Size by Region (2027-2032)
- 5.3 Tuberculosis (TB) Detection Market Dynamics
- 5.3.1 Tuberculosis (TB) Detection Industry Trends
- 5.3.2 Tuberculosis (TB) Detection Market Drivers
- 5.3.3 Tuberculosis (TB) Detection Market Challenges
- 5.3.4 Tuberculosis (TB) Detection Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Tuberculosis (TB) Detection Players by Revenue
- 6.1.1 Global Top Tuberculosis (TB) Detection Players by Revenue (2021-2026)
- 6.1.2 Global Tuberculosis (TB) Detection Revenue Market Share by Players (2021-2026)
- 6.2 Global Tuberculosis (TB) Detection Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Tuberculosis (TB) Detection Head Office and Area Served
- 6.4 Global Tuberculosis (TB) Detection Players, Product Type & Application
- 6.5 Global Tuberculosis (TB) Detection Manufacturers Established Date
- 6.6 Global Tuberculosis (TB) Detection Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Tuberculosis (TB) Detection Market Size (2021-2032)
- 7.2 North America Tuberculosis (TB) Detection Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Tuberculosis (TB) Detection Market Size by Country (2021-2026)
- 7.4 North America Tuberculosis (TB) Detection Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Tuberculosis (TB) Detection Market Size (2021-2032)
- 8.2 Europe Tuberculosis (TB) Detection Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Tuberculosis (TB) Detection Market Size by Country (2021-2026)
- 8.4 Europe Tuberculosis (TB) Detection Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Tuberculosis (TB) Detection Market Size (2021-2032)
- 9.2 Asia-Pacific Tuberculosis (TB) Detection Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Tuberculosis (TB) Detection Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Tuberculosis (TB) Detection Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Tuberculosis (TB) Detection Market Size (2021-2032)
- 10.2 South America Tuberculosis (TB) Detection Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Tuberculosis (TB) Detection Market Size by Country (2021-2026)
- 10.4 South America Tuberculosis (TB) Detection Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Tuberculosis (TB) Detection Market Size (2021-2032)
- 11.2 Middle East & Africa Tuberculosis (TB) Detection Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Tuberculosis (TB) Detection Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Tuberculosis (TB) Detection Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Danaher
- 12.1.1 Danaher Company Information
- 12.1.2 Danaher Business Overview
- 12.1.3 Danaher Revenue in Tuberculosis (TB) Detection Business (2021-2026)
- 12.1.4 Danaher Tuberculosis (TB) Detection Product Portfolio
- 12.1.5 Danaher Recent Developments
- 12.2 Roche
- 12.2.1 Roche Company Information
- 12.2.2 Roche Business Overview
- 12.2.3 Roche Revenue in Tuberculosis (TB) Detection Business (2021-2026)
- 12.2.4 Roche Tuberculosis (TB) Detection Product Portfolio
- 12.2.5 Roche Recent Developments
- 12.3 Thermal Fisher
- 12.3.1 Thermal Fisher Company Information
- 12.3.2 Thermal Fisher Business Overview
- 12.3.3 Thermal Fisher Revenue in Tuberculosis (TB) Detection Business (2021-2026)
- 12.3.4 Thermal Fisher Tuberculosis (TB) Detection Product Portfolio
- 12.3.5 Thermal Fisher Recent Developments
- 12.4 Abbott
- 12.4.1 Abbott Company Information
- 12.4.2 Abbott Business Overview
- 12.4.3 Abbott Revenue in Tuberculosis (TB) Detection Business (2021-2026)
- 12.4.4 Abbott Tuberculosis (TB) Detection Product Portfolio
- 12.4.5 Abbott Recent Developments
- 12.5 Oxford Immunotec International
- 12.5.1 Oxford Immunotec International Company Information
- 12.5.2 Oxford Immunotec International Business Overview
- 12.5.3 Oxford Immunotec International Revenue in Tuberculosis (TB) Detection Business (2021-2026)
- 12.5.4 Oxford Immunotec International Tuberculosis (TB) Detection Product Portfolio
- 12.5.5 Oxford Immunotec International Recent Developments
- 12.6 Qiagen
- 12.6.1 Qiagen Company Information
- 12.6.2 Qiagen Business Overview
- 12.6.3 Qiagen Revenue in Tuberculosis (TB) Detection Business (2021-2026)
- 12.6.4 Qiagen Tuberculosis (TB) Detection Product Portfolio
- 12.6.5 Qiagen Recent Developments
- 12.7 Hologic
- 12.7.1 Hologic Company Information
- 12.7.2 Hologic Business Overview
- 12.7.3 Hologic Revenue in Tuberculosis (TB) Detection Business (2021-2026)
- 12.7.4 Hologic Tuberculosis (TB) Detection Product Portfolio
- 12.7.5 Hologic Recent Developments
- 12.8 Hain Lifescience
- 12.8.1 Hain Lifescience Company Information
- 12.8.2 Hain Lifescience Business Overview
- 12.8.3 Hain Lifescience Revenue in Tuberculosis (TB) Detection Business (2021-2026)
- 12.8.4 Hain Lifescience Tuberculosis (TB) Detection Product Portfolio
- 12.8.5 Hain Lifescience Recent Developments
- 12.9 Epistem
- 12.9.1 Epistem Company Information
- 12.9.2 Epistem Business Overview
- 12.9.3 Epistem Revenue in Tuberculosis (TB) Detection Business (2021-2026)
- 12.9.4 Epistem Tuberculosis (TB) Detection Product Portfolio
- 12.9.5 Epistem Recent Developments
- 12.10 Creative Diagnostics
- 12.10.1 Creative Diagnostics Company Information
- 12.10.2 Creative Diagnostics Business Overview
- 12.10.3 Creative Diagnostics Revenue in Tuberculosis (TB) Detection Business (2021-2026)
- 12.10.4 Creative Diagnostics Tuberculosis (TB) Detection Product Portfolio
- 12.10.5 Creative Diagnostics Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst